Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Balchem (BCPC)

Balchem adopts executive severance policy and deferred comp match for officers

Neutral Impact 2 of 5 shareholder Written later

Balchem's Compensation Committee approved an Executive Severance Policy for executive officers on February 12, 2025, setting cash severance and benefits when officers are terminated without Cause, with enhanced terms within a Change in Control Period. The committee also approved matching officer deferred compensation contributions up to 6% of base salary, consistent with the 401(k) match.

Key points

  • Policy adopted February 12, 2025; eligibility requires at least one year of employment before termination without Cause outside a Change in Control Period
  • Within a Change in Control Period, involuntary termination triggers cash severance and full acceleration of time-based equity awards, with performance awards deemed achieved at target
  • Deferred Comp Plan contributions by executive officers matched in full up to 6% of base salary

The filing

CompanyBalchem (BCPC)
Form8-K, current report
Filed with the SECFeb 14, 2025, 4:18 PM ET
Accession number0001140361-25-004806

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 14, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.